Cargando…
The Impact of Comorbidities on the Outcomes of Egyptian COVID-19 Patients: A Follow-Up Study
OBJECTIVES: This study evaluated the clinical manifestation of COVID-19 and adverse outcomes in patients with comorbidities (outcome: death). METHODS: A comparative follow-up investigation involving 148 confirmed cases of COVID-19 was performed for a month (between April and May 2020) at Qaha Hospit...
Autores principales: | Albadawy, Reda M., Jadoon, Bismeen A., Mogahed, Mysara M., Ibrahim, Mohamed E., Essawy, Tarek S., Amin, Ahmed M. A., Abd-Elraouf, Marwa S., Elawady, Mona A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214485/ https://www.ncbi.nlm.nih.gov/pubmed/34239576 http://dx.doi.org/10.1155/2021/6662476 |
Ejemplares similares
-
Clinical Significance of HSPD1/MMP14/ITGB1/miR-6881-5P/Lnc-SPARCL1-1:2 RNA Panel in NAFLD/NASH Diagnosis: Egyptian Pilot Study
por: Albadawy, Reda, et al.
Publicado: (2021) -
Serum vascular endothelial growth factor as a tumor marker for hepatocellular carcinoma in hepatitis C virus-related cirrhotic patients
por: Alzamzamy, Ahmed, et al.
Publicado: (2021) -
Analysis of Heterozygous BRCA1 5382ins Founder Mutation in a Cohort of Egyptian Breast Cancer Female Patients Using Pyrosequencing Technique
por: Mogahed, Salwa H Gomaa, et al.
Publicado: (2020) -
The Outcomes and Adverse Drug Patterns of Immunomodulators and Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia Egyptian Patients with Hemorrhage Comorbidity
por: Hamed, Eman Mostafa, et al.
Publicado: (2023) -
Antibiograms of intensive care units at an Egyptian tertiary care hospital
por: Negm, Essamedin M., et al.
Publicado: (2021)